Protocolo de desensibilización a nivolumab sin corticoides en una paciente con cáncer renal metastásico

Sebastián Ramírez-Cruz; María Amparo Lucena-Campillo; Concepción Vila-Albelda; María Garrido-Arévalo; Lorena de Agustín-Sierra; Benito García-Díaz

doi:10.7399/fh.11348

Protocolo de desensibilización a nivolumab sin corticoides en una paciente con cáncer renal metastásico

Sebastián Ramírez-Cruz, María Amparo Lucena-Campillo, Concepción Vila-Albelda, María Garrido-Arévalo, Lorena de Agustín-Sierra, Benito García-Díaz

Resumen

Texto completo:

PDF (English) PDF

Referencias

Agencia Española de Medicamentos y Productos Sanitarios. Ficha técnica de nivolumab [Internet]. Madrid: Centro de Información de Medicamentos 2015 [accessed 13/05/2019]. Available at: https://cima.aemps.es/cima/pdfs/ft/1151014002/FT_1151014002.pdf

Scott SC, Pennell NA. Early use of systemic corticosteroids in patients with advanced NSCLC treated with nivolumab. J Thorac Oncol. 2018;13(11):1771-5. DOI: 10.1016/j.jtho.2018.06.004

Sloane D, Govindarajulu U, Harrow-Mortelliti J, Barry W, Hsu FI, Hong D, et al. Safety, costs, and efficacy of rapid drug desensitizations to chemotherapy and monoclonal antibodies. J Allergy Clin Immunol Pract. 2016;4(3):497-504. DOI: 10.1016/j.jaip.2015.12.019

Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, et al. Impact of baseline steroids on efficacy of programmed cell death-1 and programmed deathligand 1 blockade in patients with non-small-cell lung cancer. J Clin Oncol. 2018;36(28):2872-8. DOI: 10.1200/JCO.2018.79.0006

Garant A, Guilbault C, Ekmekjian T, Greenwald Z, Murgoi P, Vuong T. Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review. Crit Rev Oncol Hematol. 2017;120:86-92. DOI: 10.1016/j.critrevonc.2017.10.009

Breslow RG, Caiado J, Castells MC. Acetylsalicylic acid and montelukast block mast cell mediator–related symptoms during rapid desensitization. Ann Allergy Asthma Immunol. 2009;102(2):155-60. DOI: 10.1016/S1081-1206(10)60247-5

Chung SJ, Kang SY, Kang RY, Kim YC, Lee KH, Kim TY, et al. A new non-dilution rapid desensitization protocol successfully applied to all- grade platinum hypersensitivity. Cancer Chemother Pharmacol. 2018;82(5):777-85. DOI: 10.1007/s00280-018-3662-0

Vidal C, Méndez-Brea P, López-Freire S, Bernárdez B, Lamas MJ, Armisén M, et al. A modified protocol for rapid desensitization to chemotherapy agents. J Allergy Clin Immunol Pract. 2016;4(5):1003-5. DOI: 10.1016/j.jaip.2016.05.015

Sáenz de Santa María García M, Noguerado-Mellado B, Rojas-Pérez- Ezquerra P, Prieto-García A, Bartolomé-Zavala B, Tornero P. First case of allergy to nivolumab. J Allergy Clin Immunol Pract. 2017;5(4):1140-1. DOI: 10.1016/j.jaip.2017.01.015

Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008;122(3):574-80. DOI: 10.1016/j.jaci.2008.02.044

DOI: http://dx.doi.org/10.7399%2Ffh.11348